Rheumatology Practice Management
Subscribe to Rheumatology Practice Management

Stay up to date with rheumatology news & updates by subscribing to receive the free RPM print publications or e‑Newsletters.

RPM e-Newsletter
RPM print publication

Coding Update

Are You Aware of the CMS Policy Change Regarding JW Modifier Use?

The JW modifier is described by Current Procedural Terminology as “drug amount discarded/not administered to any patient.”1 Historically, the Centers for Medicare & Medicaid Services (CMS) allowed Medicare Administrative Contractors (MACs) the discretion to determine whether to require the JW modifier for any claims with discarded drugs or biologicals, and the specific details regarding how the discarded drug or biological information should be documented.

Read More ›